Accurate Investment Solutions’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-28,163
Closed -$2.07M 239
2020
Q1
$2.07M Buy
28,163
+27,047
+2,424% +$2.13M 1.68% 21
2019
Q4
$97K Buy
1,116
+119
+12% +$9.77K 0.06% 132
2019
Q3
$80K Sell
997
-47
-5% -$3.77K 0.06% 99
2019
Q2
$83K Buy
1,044
+53
+5% +$4.06K 0.06% 92
2019
Q1
$79K Buy
991
+3
+0.3% +$224 0.06% 89
2018
Q4
$72K Buy
988
+2
+0.2% +$141 0.07% 90
2018
Q3
$67K Sell
986
-432
-30% -$27.5K 0.05% 113
2018
Q2
$82K Buy
1,418
+7
+0.5% +$395 0.06% 113
2018
Q1
$74K Buy
1,411
+7
+0.5% +$378 0.06% 113
2017
Q4
$75K Sell
1,404
-105
-7% -$5.82K 0.06% 108
2017
Q3
$92K Buy
1,509
+540
+56% +$32.7K 0.07% 94
2017
Q2
$59K Sell
969
-64
-6% -$3.9K 0.05% 116
2017
Q1
$63K Sell
1,033
-521
-34% -$31.6K 0.05% 99
2016
Q4
$87K Buy
1,554
+527
+51% +$30.8K 0.08% 83
2016
Q3
$61K Sell
1,027
-79
-7% -$4.62K 0.06% 102
2016
Q2
$61K Buy
1,106
+5
+0.5% +$266 0.07% 94
2016
Q1
$56K Buy
1,101
+2
+0.2% +$98 0.05% 146
2015
Q4
$55K Buy
+1,099
New +$55.4K 0.05% 106

Other funds holding MRK

Accurate Investment Solutions's MRK Position: Q2 2020 in Review

Accurate Investment Solutions sold out of Merck (MRK) in Q2 2020, closing a stake of 28,163 shares — an estimated $2.07M sold.

Accurate Investment Solutions first reported a position in MRK in Q4 2015 and held it in 18 quarters. The position peaked at $2.07M in Q1 2020. 2,495 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Accurate Investment Solutions reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 28,163 Merck shares in Q2 2020, an estimated $2.07M.
  • Accurate Investment Solutions first reported a position in Merck in Q4 2015 and held it in 18 quarters.
  • Accurate Investment Solutions's Merck position peaked at $2.07M in Q1 2020.
  • 2,495 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.